From: Outcome of lung metastases due to bone giant cell tumor initially managed with observation
Case | Interval between surgery of primary tumor and discovery of lung metastasis (months) | Number of lung nodules | Size of maximum nodule (mm) | Lung lesion | Laterality | Progression of lung lesions | Time to progression from discovery of lung metastasis (months) | Treatment for lung lesions | Interval between lung metastasis and metastasectomy (months) | Follow-up period from surgery for primary tumor (months) | Follow-up period from discovery of lung metastasis (months) | Status |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 44 | NA | NA | Multiple | Bilateral | No | Â | Observation | Â | 139 | 93 | AWD |
2 | 0 | 4 | NA | Solitary | Unilateral | No | Â | Observation | Â | 34 | 33 | AWD |
3 | 0 | NA | NA | Multiple | Bilateral | Yes | 10 | Metastasectomy | 14 | 42 | 42 | AWD |
4 | 43 | NA | 5 | Multiple | Bilateral | No | Â | Observation | Â | 173 | 117 | AWD |
5 | 16 | 7 | NA | Multiple | Bilateral | Yes | 4 | Metastasectomy | 4 | 92 | 75 | NED |
6 | 35 | NA | 10 | Multiple | Bilateral | Yes | 14 | Observation | Â | 89 | 52 | AWD |
7 | 22 | 10 | 5 | Multiple | Bilateral | No | Â | Observation | Â | 42 | 20 | AWD |
8 | 0 | 4 | 5 | Multiple | Bilateral | No | Â | Observation | Â | 134 | 133 | AWD |
9 | 23 | 3 | 3 | Multiple | Bilateral | Yes | 11 | Metastasectomy | 9 | 52 | 29 | AWD |
10 | 24 | 5 | 5 | Multiple | Bilateral | Yes | 5 | Metastasectomy | 5 | 181 | 155 | NED |
11 | 11 | 6 | 5 | Multiple | Bilateral | Yes | 15 | Metastasectomy | 15 | 164 | 150 | AWD |
12 | 0 | 10 | 10 | Multiple | Bilateral | Yes | 5 | Denosumab | Â | 118 | 116 | AWD |
13 | 64 | 3 | NA | Multiple | Bilateral | No | Â | Observation | Â | 114 | 48 | AWD |
14 | 11 | 3 | 30 | Multiple | Unilateral | Yes | 6 | Metastasectomy | 62 | 141 | 128 | NED |
15 | 30 | 7 | 3 | Multiple | Bilateral | Yes | 66 | Metastasectomy | 69 | 118 | 86 | NED |
16 | 23 | 1 | 5 | Multiple | Bilateral | No | Â | Observation | Â | 76 | 51 | AWD |
17 | 46 | 4 | 5 | Multiple | Bilateral | Yes | 3 | Observation | Â | 120 | 72 | AWD |
18 | 44 | NA | NA | Multiple | Bilateral | No | Â | Observation | Â | 73 | 28 | AWD |
19 | 10 | 3 | 3 | Multiple | Bilateral | No | Â | Observation | Â | 150 | 138 | AWD |
20 | 40 | 1 | 5 | Solitary | Unilateral | No | Â | Observation | Â | 89 | 48 | AWD |
21 | 0 | 2 | 12 | Multiple | Bilateral | Yes | 5 | Metastasectomy | 6 | 183 | 181 | NED |
22 | 0 | NA | 6 | Multiple | Bilateral | Yes | 36 | Denosumab | Â | 87 | 91 | AWD |